Aera Therapeutics
Aera Therapeutics is a biotechnology firm that employs its own protein nanoparticle (PNP) delivery platform.
Aera Therapeutics is a business in biopharma, biotechnology, product research based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2021.
Within the biopharma, biotechnology, product research space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Greater Boston Area, East Coast, New England, Northeastern US.
Its current recorded stage is Series_B.
Its team size is recorded as c_00101_00250 employees.
Total disclosed funding stands at about $193M.
| Sector | Biopharma, Biotechnology, Product Research |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Country | United States |
| Founded | 2021 |
| Employees | c_00101_00250 |
| Stage | series_b |
| Total funding | $193,000,000 |
Website: aeratx.com
Browse related
Sign in to view the contact information we hold for Aera Therapeutics.
Create a free account
Create a free account